osimertinib
astrazeneca
['breast', 'adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
#esmo22 #lcsm discussing adaura updates using osi in adjuvant setting: the trajectory is different according to the stage, opening the scenario of potential diff duration of response: are we following the trajectory of hormon+ high-risk resected breast cancer? 
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM